AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
218,50 $ ↑6,00 (2,82%)
2026-06-03
DEL PRIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionTrust Co
Latest Disclosed Ownership10,294 shares
Latest Disclosed Value $ 2,238,842
Trust Co reports 3.94% increase in ownership of 0QCV / AbbVie Inc.

On April 13, 2026 - Trust Co filed a 13F-HR form disclosing ownership of 10,294 shares of AbbVie Inc. (GB:0QCV) valued at $2,228,857 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 9,904 shares of AbbVie Inc.. This represents a change in shares of 3.94% during the quarter. The current value of the position is $2,249,239 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE INC COM Stock 00287Y109 10,294 390 3.94 2,239 -1.06 0.2098
2026-01-15 2025-12-31 13F ABBVIE INC COM Stock 00287Y109 9,904 7,499 311.81 2,263 306.83 0.2122
2025-10-06 2025-09-30 13F AbbVie COM 00287Y109 2,405 281 13.23 557 41.12 0.0570
2025-07-07 2025-06-30 13F AbbVie COM 00287Y109 2,124 0 0.00 394 -11.46 0.0445
2025-04-08 2025-03-31 13F AbbVie COM 00287Y109 2,124 0 0.00 445 18.04 0.0528
2025-01-14 2024-12-31 13F AbbVie COM 00287Y109 2,124 204 10.62 377 -0.53 0.0432
2024-10-03 2024-09-30 13F AbbVie COM 00287Y109 1,920 3 0.16 379 15.55 0.0456
2024-07-15 2024-06-30 13F AbbVie COM 00287Y109 1,917 0 0.00 329 -6.02 0.0425
2024-04-11 2024-03-31 13F AbbVie COM 00287Y109 1,917 0 0.00 349 17.51 0.0459
2024-01-10 2023-12-31 13F AbbVie COM 00287Y109 1,917 -330 -14.69 297 -11.08 0.0382
2023-12-04 2023-09-30 13F AbbVie COM 00287Y109 2,247 -128 -5.39 335 4.70 0.0540
2023-07-10 2023-06-30 13F AbbVie COM 00287Y109 2,375 -128 -5.11 320 -19.85 0.0478
2023-04-07 2023-03-31 13F AbbVie COM 00287Y109 2,503 -111 -4.25 399 -5.69 0.0605
2023-01-09 2022-12-31 13F AbbVie COM 00287Y109 2,614 91 3.61 0 -100.00 0.0684
2022-10-11 2022-09-30 13F AbbVie COM 00287Y109 2,523 -177 -6.56 339 -18.12 0.0742
2022-07-06 2022-06-30 13F AbbVie COM 00287Y109 2,700 2 0.07 414 -5.26 0.0893
2022-04-08 2022-03-31 13F AbbVie COM 00287Y109 2,698 -40 -1.46 437 17.79 0.0853
2022-01-14 2021-12-31 13F AbbVie COM 00287Y109 2,738 -100 -3.52 371 21.24 0.0866
2021-10-20 2021-09-30 13F AbbVie COM 00287Y109 2,838 0 0.00 306 -4.37 0.0784
2021-07-14 2021-06-30 13F AbbVie COM 00287Y109 2,838 85 3.09 320 7.38 0.2245
2021-04-08 2021-03-31 13F AbbVie COM 00287Y109 2,753 350 14.57 298 15.95 0.2148
2021-01-12 2020-12-31 13F AbbVie COM 00287Y109 2,403 92 3.98 257 27.23 0.2031
2020-10-06 2020-09-30 13F AbbVie COM 00287Y109 2,311 0 0.00 202 -11.01 0.1699
2020-07-17 2020-06-30 13F AbbVie COM 00287Y109 2,311 0 0.00 227 28.98 0.2158
2020-04-07 2020-03-31 13F AbbVie COM 00287Y109 2,311 -440 -15.99 176 -27.87 0.1940
2020-01-07 2019-12-31 13F AbbVie COM 00287Y109 2,751 -1,000 -26.66 244 -14.08 0.2145
2019-10-09 2019-09-30 13F AbbVie COM 00287Y109 3,751 100 2.74 284 6.77 0.2682
2019-07-08 2019-06-30 13F AbbVie COM 00287Y109 3,651 0 0.00 266 -9.52 0.2449
2019-04-08 2019-03-31 13F AbbVie COM 00287Y109 3,651 0 0.00 294 -12.76 0.1714
2019-01-22 2018-12-31 13F AbbVie COM 00287Y109 3,651 0 0.00 337 -2.32 0.1875
2018-10-09 2018-09-30 13F AbbVie COM 00287Y109 3,651 -135 -3.57 345 -1.71 0.1557
2018-07-10 2018-06-30 13F AbbVie COM 00287Y109 3,786 125 3.41 351 1.15 0.1606
2018-04-09 2018-03-31 13F AbbVie COM 00287Y109 3,661 185 5.32 347 3.27 0.1281
2018-03-09 2017-12-31 13F/A-1 AbbVie COM 00287Y109 3,476 0 0.00 336 8.74 0.1388
2018-01-11 2017-12-31 13F AbbVie COM 00287Y109 3,476 0 336
2017-10-12 2017-09-30 13F AbbVie COM 00287Y109 3,476 0 0.00 309 22.62 0.1700
2017-07-07 2017-06-30 13F AbbVie COM 00287Y109 3,476 -150 -4.14 252 6.78 0.1165
2017-04-06 2017-03-31 13F AbbVie COM 00287Y109 3,626 -68 -1.84 236 2.16 0.1072
2017-01-12 2016-12-31 13F AbbVie COM 00287Y109 3,694 -38,491 -91.24 231 -91.32 0.1174
2016-10-19 2016-09-30 13F AbbVie ABBVIE INC COM 00287Y109 42,185 38,559 1,063.40 2,661 1,087.95 1.1671
2016-07-08 2016-06-30 13F AbbVie COM 00287Y109 3,626 0 0.00 224 8.21 0.0856
2016-04-08 2016-03-31 13F AbbVie COM 00287Y109 3,626 995 37.82 207 33.55 0.0947
2016-01-26 2015-12-31 13F AbbVie COM 00287Y109 2,631 -137 -4.95 156 2.65 0.0722
2015-10-13 2015-09-30 13F AbbVie COM 00287Y109 2,768 273 10.94 151 -10.12 0.0857
2015-07-10 2015-06-30 13F AbbVie COM 00287Y109 2,495 1,495 149.50 168 184.75 0.1050
2015-05-07 2015-03-31 13F AbbVie COM 00287Y109 1,000 1,000 59 0.0373
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.